{"id":"diprosone-ointment","safety":{"commonSideEffects":[{"rate":"null","effect":"Skin atrophy"},{"rate":"null","effect":"Hypersensitivity reactions"}]},"_chembl":{"chemblId":"CHEMBL2108523","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Diprosone ointment contains betamethasone valerate, a synthetic glucocorticoid that acts by binding to the glucocorticoid receptor, leading to anti-inflammatory and immunosuppressive effects.","oneSentence":"Glucocorticoid receptor agonist","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:33:06.143Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atopic dermatitis"},{"name":"Psoriasis"},{"name":"Seborrhoeic dermatitis"}]},"trialDetails":[{"nctId":"NCT00875277","phase":"PHASE2","title":"A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2009-04","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT01422434","phase":"PHASE3","title":"LEO 90105 Ointment in Japanese Subjects With Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2011-07","conditions":"Psoriasis","enrollment":676},{"nctId":"NCT03806790","phase":"PHASE3","title":"Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2019-01-24","conditions":"Psoriasis Vulgaris","enrollment":182},{"nctId":"NCT02668692","phase":"PHASE3","title":"LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2016-02","conditions":"Psoriasis Vulgaris","enrollment":213},{"nctId":"NCT01347255","phase":"PHASE2","title":"A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2011-05","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT01946386","phase":"PHASE1","title":"A Vasoconstriction Study With LEO 90100","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2013-09","conditions":"Psoriasis Vulgaris","enrollment":35},{"nctId":"NCT00248456","phase":"PHASE4","title":"Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2005-10","conditions":"Psoriasis Vulgaris","enrollment":320},{"nctId":"NCT01466478","phase":"PHASE1","title":"An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis Vulgaris","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2011-11","conditions":"Psoriasis Vulgaris","enrollment":24},{"nctId":"NCT03476746","phase":"PHASE1","title":"Dermatopharmacokinetic Trial of LEO 90100 Foam","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2018-03-20","conditions":"Healthy","enrollment":58},{"nctId":"NCT00437255","phase":"PHASE4","title":"Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2006-08","conditions":"Plaque Psoriasis","enrollment":122},{"nctId":"NCT00762658","phase":"PHASE1","title":"A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test","status":"COMPLETED","sponsor":"Pfizer","startDate":"2007-11-30","conditions":"Psoriasis","enrollment":12},{"nctId":"NCT03004339","phase":"PHASE1","title":"Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test","status":"COMPLETED","sponsor":"DFB Soria, LLC","startDate":"2016-08","conditions":"Plaque Psoriasis","enrollment":13},{"nctId":"NCT01707043","phase":"PHASE4","title":"Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris","status":"COMPLETED","sponsor":"Wake Forest University","startDate":"2012-10","conditions":"Plaque Psoriasis","enrollment":20},{"nctId":"NCT02973776","phase":"PHASE1","title":"Vasoconstriction Trial With LEO 90100 Aerosol Foam","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2016-12","conditions":"Psoriasis Vulgaris","enrollment":36},{"nctId":"NCT02999776","phase":"PHASE1","title":"Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type Psoriasis","status":"UNKNOWN","sponsor":"Pantec Biosolutions AG","startDate":"2016-11","conditions":"Psoriatic Plaque","enrollment":30},{"nctId":"NCT02955576","phase":"NA","title":"Microneedle Patch for Psoriatic Plaques","status":"UNKNOWN","sponsor":"The Catholic University of Korea","startDate":"2016-09","conditions":"Psoriasis, Administration, Topical","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Diprosone® ointment","genericName":"Diprosone® ointment","companyName":"LEO Pharma","companyId":"leo-pharma","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Glucocorticoid receptor agonist Used for Atopic dermatitis, Psoriasis, Seborrhoeic dermatitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}